By some estimates, one billion people worldwide have vitamin D deficiency or insufficiency, a vitamin whose actions are more like a hormone and involved in thousands of critical reactions in the body. Although vitamin D is produced by the skin when in contact with sunlight, many factors prevent this from happening, like pollution and smog, clothing, sunscreen, darker shade of skin, or winter season.
Vitamin D plays an important role in the innate and adaptive immune system, and has been shown to have antiviral activity. Vitamin D is needed for proper absorption of calcium from the digestive tract, and researchers suggest that vitamin D supplementation may decrease bone turnover and increase bone mineral density.
There is extensive research supporting the use of Vitamin K supplementation on decreasing arterial calcium deposits. Consuming the combination of Vitamin D with K promotes the absorption of dietary calcium, while ensuring the calcium is deposited into your bones, and not your arteries.
All PrimeHealth Formulas Meet or Exceed cGMP Quality Standards
Prime D + K 120 Count Ingredients
Vitamin D3 (cholecalciferol) 125 mcg (5000 IU) 625%, Vitamin K2 (as menaquinone-7) 90 mcg 75%, HPMC (capsule), microcrystalline cellulose, ascorbyl palmitate, and silica.
Prime D + K 120 Count Directions
Take 1 daily, or as suggested by your healthcare provider. Individuals taking medication should discuss potential interactions with their healthcare practitioner. Consider total vitamin K intake (food + supplements) if you are taking blood-thinning medication. Do not use if the tamper seal is damaged.
Prime D + K 120 Count Does NOT Contain
Wheat, gluten, yeast, soy protein, dairy products, fish, shellfish, peanuts, tree nuts, egg, ingredients derived from genetically modified organisms (GMOs), artificial colors, artificial sweeteners, or artificial preservatives.
Prime D + K 120 Count Discussion
Naturally occurring vitamin K is found as either K1 (phylloquinone), which is derived from food sources such green leafy vegetables, or K2 (menaquinones). Menaquinones are designated as MK-n, where n denotes the length of the molecule’s aliphatic side chain. Menaquinones are synthesized by bacteria and can be obtained from animal-based and fermented foods. Structural differences between K1 and K2 impact their bioavailability and bioactivity. Furthermore, among menaquinones, menaquinone-7 (MK-7), with its longer side chain, is very hydrophobic. Compared to K1, MK-7’s physiochemical properties make it highly transportable by plasma lipoproteins, increase its extrahepatic (bones, arteries, etc.) availability, and produce its long half-life.[1-3]
Absorption of K1 from food can be limited due to its membrane-bound nature and the individual consumer’s digestive and absorptive variability. Moreover, adequate consumption of foods high in K2 can be challenging. Therefore, dietary supplementation is an important option. In addition, research suggests that higher levels of menaquinones are needed than were previously thought. Supplementary vitamin K can be found in three forms: synthetic K1; MK-4, which is structurally similar to K1; and natural, long-chain MK-7. PrimeHealth provides MK-7 as Vitamk7TM, a naturally derived and solvent-free vitamin K2 that has been obtained through a patent-granted biofermentation process of Bacillus subtilis natto cultures.*
MK-7 Bioavailability Increases Extrahepatic Tissue Utilization
Schurgers et al conducted human studies to compare the in vivo properties of orally administered K1 and MK-7. The results supported better bioavailability and utilization of MK-7. Expressed as AUC96, MK-7 demonstrated a six-fold better half-life, a seven- to eight-fold higher dose- response level, and a three times higher carboxylated to uncarboxylated osteocalcin ratio (cOC:ucOC†). Furthermore, on a molar basis, MK-7 is a three-to-four times more potent antidote for oral anticoagulation than is K1. Researchers note that, aside from sensitive individuals, “MK-7 supplements containing more than 50 mcg/d may interfere with oral anticoagulant treatment, whereas doses of at least 50 mcg are not likely to affect the INR value in a relevant way.” Nonetheless, practitioners should closely monitor patients taking anticoagulants.*
While studies on the absorption and bioavailability of MK-4 at nutritional levels (i.e., doses of 500 mcg/d or lower) suggest less efficacy compared to longer-chain menaquinones at similar doses, this remains subject to debate. It is possible that rapid uptake of MK-4 could account for its observed lack of detection in serum after oral administration, but more studies are needed for clarification.*
Among the dietary factors critical to bone health, vitamin K has emerged as a key player. Vitamin K is believed to be necessary for bone mineralization. Through carboxylation, vitamin K activates osteocalcin, the protein needed to bind calcium to the mineral matrix in bone. Several studies have demonstrated the efficacy of MK-7 (e.g., doses of 45-90 mcg/d) to increase osteocalcin carboxylation and to increase the cOC:ucOC ratio. A high cOC:ucOC ratio is associated with bone health.[1,2,4] A recent in vitro study also showed an osteogenic effect of MK-7 administration on human mesenchymal cell differentiation. In addition, the vitamin may protect bone integrity by reducing the synthesis of prostaglandin E2 or interleukin-6 by osteoclasts. Animal and human studies have demonstrated a significant beneficial effect of MK-7 supplementation on bone health.[8-10] Vitamin K and vitamin D share some similar characteristics and are believed to act synergistically.*
Cardiovascular and Other Health Benefits
Vitamin K benefits cardiovascular health by participating in the carboxylation of matrix GLA protein (MGP), a protein regarded to be the most potent inhibitor of arterial calcification. Researchers have demonstrated that supplementation with vitamin K reduces arterial calcium deposits[1,3,12] and that long-term intake of long-chain menaquinones is inversely correlated with calcium accumulation in arteries.*
Vitamin K has specific receptor binding sites that allow it to regulate gene activity. Besides its gene-mediating effects upon critical proteins, the vitamin can also bind with the steroid and xenobiotic receptors and influence their expression. In addition, vitamin K also demonstrates antioxidant activity; reduces levels of certain markers, such as acute phase reactants (e.g., C-reactive protein); and participates in the induction of apoptosis.*
Vitamin D (as D3)
Although vitamin D3 (cholecalciferol) is made in the skin when 7-dehydrocholesterol reacts with sunlight, many things affect the degree to which this biosynthesis occurs, including time of day, seasons, location, smog/pollution, clothing, shade of skin (darker skin requires more sun), and sunscreen use. Low-cholesterol diets and certain cholesterol therapies can also affect vitamin D formation. By some estimates, one billion people worldwide have vitamin D deficiency or insufficiency. The body needs vitamin D to absorb calcium, and the importance of vitamin D.
We also have Prime D + K 60 Count.
- Tsiaras WG, Weinstock MA. Factors influencing vitamin d status. Acta Derm Venereol. 2011 Mar;91(2):115-24. [PMID: 21384086]
- Lips P, van Schoor NM. The effect of vitamin D on bone and osteoporosis. Best Pract Res Clin Endocrinol Metab. 2011 Aug;25(4):585-91. [PMID: 21872800]
- Brugè F, Bacchetti T, Principi F, et al. Olive oil supplemented with menaquinone-7 significantly affects osteocalcin carboxylation. Br J Nutr. 2011 Oct;106(7):1058-62. [PMID: 21736837]
- Beulens JW, Bots ML, Atsma F, et al. High dietary menaquinone intake is associated with reduced coronary calcification. Atherosclerosis. 2009 Apr;203(2):489-93. [PMID: 18722618]
- Schurgers LJ, Vermeer C. Differential lipoprotein transport pathways of K-vitamins in healthy subjects. Biochim Biophys Acta. 2002 Feb 15;1570(1):27- 32. [PMID: 11960685]
- Geleijnse JM, Vermeer C, Grobbee DE, et al. Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study. J Nutr. 2004 Nov;134(11):3100-05. [PMID: 15514282]
- Teymoori-Rad M, Shokri F, Salimi V, Marashi SM. The interplay between vitamin D and viral infections. Rev Med Virol. 2019 Mar;29(2):e2032. doi: 10.1002/rmv.2032. Epub 2019 Jan 6. [PMID: 30614127]
- Cynthia Aranow, MD. Vitamin D and the Immune System. J Investig Med. 2011 Aug; 59(6): 881–886. [PMID: 21527855]